glp-1 popularity Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline Poll: 1 in 8 Adults

Future of GLP-1 Agonists ******** from Ian Blumer, MD, FRCPC, Charles H Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada, Author of Diabetes for Canadians for Dummies , and Celiac Disease for Dummies Compiled by Farhan Guard and Eric Nielsen, Ambulatory Care Pharmacy rotation students

Provincial healthcare systems do not cover research peptides, and most private insurance plans exclude them as well

M.GraceM

Sewerin GmbH & Co

Peptide hormones like GLP-1 are relatively large and structurally complex molecules

We reviewed Sikiric 1993-2026 (Zagreb, over 150 BPC-157 papers), the AJSM 2026 systematic review (35 preclinical studies), the 2026 pilot PK study in two healthy subjects, and the February 2026 STAT review